Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toppoly Optoelectronics CorpfiledCriticalToppoly Optoelectronics Corp
Priority to TW95116616ApriorityCriticalpatent/TWI313570B/en
Publication of TW200743405ApublicationCriticalpatent/TW200743405A/en
Application grantedgrantedCritical
Publication of TWI313570BpublicationCriticalpatent/TWI313570B/en
A laser evaporation apparatus is for evaporating a first evaporating substance and a second evaporating substance. The laser evaporation apparatus includes a beam-splitting element, a first containing element and a second containing element. In this case, the beam-splitting element receives a source laser to separate the source laser to a first laser light and a second laser light. The first containing element contains the first evaporating substance, and the first laser light illuminates the first evaporating substance to evaporate the first substance. The second containing element contains the second evaporating substance, and the second laser light illuminates the second evaporating substance to evaporate the second evaporating substance. Besides, a laser evaporation method applied with the laser evaporation apparatus is provided.
TW95116616A2006-05-102006-05-10Laser evaporation apparatus and method thereof
TWI313570B
(en)
Stable, liquid formulation containing antibody comprising arginine and methionine; A method of inhibiting the deamidation of molecules of an antibody comprising adding arginine to the liquid formulation.
Compounds derived from 2-oxo-2,5-dihydro pyrrole propionamide, glucokinase activators; preparation procedure; pharmaceutical composition comprising said compounds; and its use in the treatment of diabetes mellitus.
COMPOUNDS DERIVED FROM BICYCLES, CEPT INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, AMONG OTHER ILLNESSES.
method for connecting a generic element to a content delivery architecture in a push content delivery system and mediator that connects a generic element to a content delivery architecture in a push content delivery system
PROCEDURE FOR PREPARING ATORVASTATIN AMORFA THAT INCLUDES DISSOLVING ATORVASTATIN IN A SOLUTION THAT INCLUDES A HYDROXYLIC SOLVENT AND FAST EVAPORATE SUCH SOLVENT SINCE THE SOLUTION; PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, USEFUL IN TR